12/2
10:24 am
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
High
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
12/2
07:07 am
jspr
Form 8-K Jasper Therapeutics, For: Dec 02
High
Report
Form 8-K Jasper Therapeutics, For: Dec 02
11/14
05:23 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
11/14
12:19 pm
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Medium
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
11/12
01:05 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
Low
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
11/10
08:17 am
jspr
Form 10-Q Jasper Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Jasper Therapeutics, For: Sep 30
11/10
08:05 am
jspr
Form 8-K Jasper Therapeutics, For: Nov 10
High
Report
Form 8-K Jasper Therapeutics, For: Nov 10
11/7
12:45 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY